About Brain Tumor Therapeutics
Brain tumor therapeutics helps cure abnormal growth of cells inside the brain. Owing to rising cases of brain disorder related death, companies are focusing on developing remedial methods. With over 769,970 estimated cases in United States alone till 2019, brain tumor is causing significant harm to individuals' health. Recently, various therapeutics techniques have been developed yet, a lot has to be done.
|Value (USD Million)
Brain Tumor Therapeutics is a fragmented market due to the presence of various players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Brain Tumor Therapeutics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
NOVARTIS [Switzerland], F. HOFFMAN LA-ROCHE LTD. [Switzerland], MERCK & CO. Inc. [United States], IMMUNOCELLULAR THERAPEUTICS LTD. [United States], NOVOCURE [United States], DEL MAR PHARMACEUTICALS INC. [Canada] and MOLECULIN BIOTEC. [United States] are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Siemens Healthineers [Germany], Hitachi Healthcare [United States], Philips Healthcare [Netherlands], Canon Medical Systems Corporation [Japan] and Shimadzu Corp [Japan].
AMA Research has segmented the market of Global Brain Tumor Therapeutics market by Type (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing and EEG) and Region.
On the basis of geography, the market of Brain Tumor Therapeutics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment Type, the sub-segment i.e. Surgery will boost the Brain Tumor Therapeutics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tumor Type, the sub-segment i.e. Primary Brain Tumor will boost the Brain Tumor Therapeutics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Emerging Applications of Gene Therapy in Regenerative Medicine Technological Advances in Regenerative Medicine (Stem Cell, Tissue Engineering, and Nanotechnology)
Market Growth Drivers:
Increasing Adoption of Stem Cell Technology and Growing Prevalence of Chronic Diseases
High Cost of Treatment and Less Awareness and Regulatory and Ethical Issues Pertaining Stem Cell, Tissues Engineering and Regenerative Medicine
High Investment & Funding To Support Development of RM
Market Leaders and their expansionary development strategies
In December 2023, GT Medical Technologies, Inc. ("GT Medical Technologies"), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, announced it has agreed to acquire substantially all of the radioactive Cesium-131 seed assets and related business infrastructure from Isoray Medical, which is a subsidiary of Perspective Therapeutics, Inc. ("Isoray"). GT Medical Technologies' GammaTile Therapy is FDA-cleared to treat patients with operable brain tumors to eliminate residual tumor cells.
In March 2023, New research has shown that the blood vessels that feed aggressive brain tumours have receptors that could allow a new type of drug-containing nanoparticle to be used to starve the tumours of the energy they use to grow and spread, and also cause other disruptions to their adapted existence, even killing themselves.
Key Target AudienceHealthcare Sectors, Potential Investors, Research Institutes, Government Agencies and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.